Olca Baştürk

20.0k total citations · 3 hit papers
183 papers, 8.3k citations indexed

About

Olca Baştürk is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Olca Baştürk has authored 183 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Oncology, 89 papers in Surgery and 55 papers in Epidemiology. Recurrent topics in Olca Baştürk's work include Pancreatic and Hepatic Oncology Research (99 papers), Neuroendocrine Tumor Research Advances (50 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (40 papers). Olca Baştürk is often cited by papers focused on Pancreatic and Hepatic Oncology Research (99 papers), Neuroendocrine Tumor Research Advances (50 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (40 papers). Olca Baştürk collaborates with scholars based in United States, Türkiye and South Korea. Olca Baştürk's co-authors include Volkan Adsay, David S. Klimstra, Laura H. Tang, İpek Çoban, Ralph H. Hruban, Pelin Bağcı, Peter J. Allen, Serdar Balcı, Aleodor A. Andea and Jeanette D. Cheng and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Olca Baştürk

168 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

2022 486 citations Olca Baştürk, Lodewijk A.A. Brosens et al. profile →
The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms

2015 341 citations Olca Baştürk, Ralph H. Hruban et al. profile →
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

2024 124 citations Shubham Pant, Zev A. Wainberg et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olca Baştürk United States	50	6.1k	3.3k	3.1k	1.4k	1.3k	183	8.3k
Kazuaki Shimada Japan	58	6.6k 1.1×	6.7k 2.0×	2.7k 0.9×	3.7k 2.5×	185 0.1×	293	12.8k
Tsutomu Takashima Japan	46	2.0k 0.3×	1.5k 0.5×	2.0k 0.6×	1.2k 0.9×	169 0.1×	411	8.3k
Masahiko Ohsawa Japan	49	2.5k 0.4×	869 0.3×	678 0.2×	1.2k 0.9×	296 0.2×	292	7.2k
Jeremy S. Wilson Australia	52	5.1k 0.8×	4.8k 1.5×	1.5k 0.5×	377 0.3×	68 0.1×	159	9.1k
Yao Fu China	38	1.7k 0.3×	1.1k 0.3×	1.0k 0.3×	2.0k 1.4×	90 0.1×	215	5.4k
Kazuhiro Tsukada Japan	43	2.0k 0.3×	2.9k 0.9×	592 0.2×	2.0k 1.4×	56 0.0×	289	6.2k
C. Christofer Juhlin Sweden	36	1.2k 0.2×	1.5k 0.5×	672 0.2×	476 0.3×	374 0.3×	196	4.6k
Stuart D. Wilson United States	32	1.7k 0.3×	1.7k 0.5×	1.4k 0.4×	746 0.5×	490 0.4×	88	3.7k
Tomi P. Mäkelä Finland	61	2.5k 0.4×	1.2k 0.4×	764 0.2×	398 0.3×	229 0.2×	190	12.9k
Soon Won Hong South Korea	40	886 0.1×	1.5k 0.5×	396 0.1×	720 0.5×	90 0.1×	224	5.9k

Countries citing papers authored by Olca Baştürk

Since Specialization

Citations

This map shows the geographic impact of Olca Baştürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olca Baştürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olca Baştürk more than expected).

Fields of papers citing papers by Olca Baştürk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olca Baştürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olca Baştürk. The network helps show where Olca Baştürk may publish in the future.

Co-authorship network of co-authors of Olca Baştürk

This figure shows the co-authorship network connecting the top 25 collaborators of Olca Baştürk. A scholar is included among the top collaborators of Olca Baştürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olca Baştürk. Olca Baştürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Artem, Gökhan Ünlü, Rebecca C. Timson, et al.. (2025). Data from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling.

Khan, Artem, Gökhan Ünlü, Rebecca C. Timson, et al.. (2025). Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling. Cancer Discovery. 15(12). 2437–2449.

Keane, Fergus, Richard Tuli, Catherine O’Connor, et al.. (2024). Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights.. Journal of Clinical Oncology. 42(16_suppl). 4174–4174.

Singhal, Anupriya, Stefan Torborg, Jung Yun Kim, et al.. (2024). A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer. Cancer Discovery. 14(11). 2122–2134. 21 indexed citations

Pant, Shubham, Zev A. Wainberg, Colin D. Weekes, et al.. (2024). Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial. Nature Medicine. 30(2). 531–542. 124 indexed citations breakdown →

Baştürk, Olca & Volkan Adsay. (2023). Early Cancerous Lesions of the Pancreas and Ampulla. Gastroenterology Clinics of North America. 53(1). 57–84. 1 indexed citations

Mattiolo, Paola, Huamin Wang, Olca Baştürk, et al.. (2023). Comprehensive characterisation of acinar cystic transformation of the pancreas: a systematic review. Journal of Clinical Pathology. 76(11). 740–746. 4 indexed citations

Mandelker, Diana, Antonio Marra, Nikita Mehta, et al.. (2023). Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. npj Precision Oncology. 7(1). 34 indexed citations

Wood, Laura D., Volkan Adsay, Olca Baştürk, et al.. (2023). Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms. Pancreatology. 23(7). 878–891. 24 indexed citations

10.

Paolino, Gaetano, Iréne Esposito, Seung‐Mo Hong, et al.. (2022). Intraductal tubulopapillary neoplasm (ITPN) of the pancreas: a distinct entity among pancreatic tumors. Histopathology. 81(3). 297–309. 9 indexed citations

11.

Monette, Sébastien, Adam O. Michel, Achiude Bendet, et al.. (2021). Transarterial Embolization of Liver Cancer in a Transgenic Pig Model. Journal of Vascular and Interventional Radiology. 32(4). 510–517.e3. 25 indexed citations

12.

Hornick, Jason L., Rhonda K. Yantiss, Laura W. Lamps, et al.. (2018). USCAP 2018 Abstracts: Genitourinary Pathology (894–1126). Modern Pathology. 31(S2). 323a–403. 3 indexed citations

13.

Fu, Ya–Yuan, Adrien Grimont, Kelly J. Lafaro, et al.. (2017). PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk. Cancer Research. 77(8). 1868–1879. 72 indexed citations

14.

Jordan, Emmet, Olca Baştürk, Steven D. Leach, et al.. (2016). Clinical and Molecular Analysis of Adenosquamous Carcinoma of the Pancreas. JOP, journal of the pancreas. 17(6). 1 indexed citations

15.

Chmielecki, Juliann, Katherine E. Hutchinson, Garrett M. Frampton, et al.. (2014). Comprehensive Genomic Profiling of Pancreatic Acinar Cell Carcinomas Identifies Recurrent RAF Fusions and Frequent Inactivation of DNA Repair Genes. Cancer Discovery. 4(12). 1398–1405. 126 indexed citations

16.

Wei, Jian‐Jun, Xinyu Wu, Yi Peng, et al.. (2010). Regulation of HMGA1 Expression by MicroRNA-296 Affects Prostate Cancer Growth and Invasion. Clinical Cancer Research. 17(6). 1297–1305. 67 indexed citations

17.

Zhang, Pengfei, Joseph Bonventre, Susan C. Abraham, et al.. (2006). Liver & Pancreas. Laboratory Investigation. 86. 266–284. 1 indexed citations

18.

Niraj, Ashutosh, et al.. (2006). Localized gastric amyloidosis. 30(7). 73–79. 1 indexed citations

19.

Zhang, Hui, Olca Baştürk, Marini Othman, et al.. (2005). Neuropathology. Modern Pathology. 18. 291–296.

20.

Baştürk, Olca, et al.. (2002). Long-term variations of surface chlorophyll a and primary production in the open Black Sea. Marine Ecology Progress Series. 230. 11–28. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact